Expression of genes FOLR1, BAG1 and LAPTM4B in functioning and non-functioning pituitary adenomas

Folia Neuropathologica

Volumn 50, Issue 3, 2012, Pages 277-286

  Larysz, Dawid ^a,b   Zebracka Gala, Jagoda ^c   Rudnik, Adam ^a   Hasse Lazar, Kornelia ^c   Kowalska, Małgorzata ^c   Jarza̧b, Michał ^c   Król, Aleksandra ^c   Szpak Ulczok, Sylwia ^c   Bazowski, Piotr ^a   Jarza̧b, Barbara ^c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Maria Sklodowska Curie Memorial Cancer Centre   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Gene expression; Pituitary adenoma; Real time quantitative PCR

Indexed keywords

BAG 1 PROTEIN; FOLATE RECEPTOR 1; LYSOSOMAL PROTEIN TRANSMEMBRANE 4 BETA; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INVASION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84866987816     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2012.30528     Document Type: Article

References (24)

1. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 2001; 8: 287-305. (Pubitemid 34019376)
2. Asa SL, Ezzat S. Genetics and proteomics of pituitary tumors. Endocrine 2005; 28: 43-47. (Pubitemid 43004800)
3. Clifton GT, Sears AK, Clive KS, Holmes JP, Mittendorf EA, Ioannides CG, Ponniah S, Peoples GE. Folate receptor α: a storied past and promising future in immunotherapy. Hum Vaccin 2011; 7: 183-190.
4. Elnakat H, Ratnam M. Role of folate receptor genes in reproduction and related cancers. Front Biosci 2006; 11: 506-519. (Pubitemid 43258160)
5. Evans CO, Moreno CS, Zhan X, McCabe MT, Vertino PM, Desiderio DM, Oyesiku NM. Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses. Pituitary 2008; 11: 231-245.
6. Evans CO, Reddy P, Brat DJ, O'Neill EB, Craige B, Stevens VL, Oyesiku NM. Differential expression of folate receptor in pituitary adenomas. Cancer Res 2003; 63: 4218-4224. (Pubitemid 36917949)
7. Evans CO, Yao C, Laborde D, Oyesiku NM. Folate receptor expression in pituitary adenomas cellular and molecular analysis. Vitam Horm 2008; 79: 235-266.
8. Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, Oyesiku NM. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2001; 86: 3097-3107. (Pubitemid 32673472)
9. Farrell WE, Clayton RN. Epigenetic change in pituitary tumorigenesis. Endocr Relat Cancer 2003; 10: 323-330. (Pubitemid 36758658)
10. Farrell WE, Clayton RN. Molecular pathogenesis of pituitary tumors. Front Neuroendocrinol 2000; 21: 174-198. (Pubitemid 30495781)
11. Kasper G, Vogel A, Klaman I, Gröne J, Petersen I, Weber B, Castaños-Vélez E, Staub E, Mennerich D. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett 2005; 224: 93-103. (Pubitemid 40720370)
12. Kelemen LE. The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer 2006; 119: 243-250.
13. Kikuchi R, Noguchi T, Takeno S, Funada Y, Moriyama H, Uchida Y. Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas. Br J Cancer 2002; 87: 1136-1139. (Pubitemid 35418109)
14. Leamon CP, Reddy JA. Folate-targeted chemotherapy. Adv Drug Deliv Rev 2004; 56: 1127-1141. (Pubitemid 38496512)
15. Liu X, Ma S, Yao Y, Li G, Feng M, Deng K, Dai C, Cai F, Li Y, Zhang B, Wang R. Differential Expression of Folate Receptor Alpha in Pituitary Adenomas and Its Relationship to Tumor Behavior. Neurosurgery 2012; 70: 1274-1280.
16. Molitch ME, Russell EJ. The pituitary incidentaloma. Ann Intern Med 1990; 312: 1364-1370.
17. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 2005; 65: 10214-10222. (Pubitemid 41743713)
18. Morris DG, Musat M, Czirjak S, Hanzély Z, Lillington DM, Korbonits M, Grossman AB. Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 2005; 153: 143-151. (Pubitemid 41030525)
19. Peters DG, Kudla DM, DeLoia J, Chu TJ, Fairfull L, Edwards RP, Ferrell RE. Comparative Gene Expression Analysis of Ovarian Carcinoma and Normal Ovarian Epithelium by Serial Analysis of Gene Expression. Cancer Epidemiol Biomarkers Prev 2005; 14: 1717-1723. (Pubitemid 40995085)
20. Rorke S, Murphy S, Khalifa M, Chernenko G, Tang SC. Prognostic significance of BAG-1 expression in nonsmall cell lung cancer. Int J Cancer 2001; 95: 317-322. (Pubitemid 32847043)
21. Schittenhelm J, Psaras T, Meyermann R, Honegger J, Beschorner R. Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasms. Folia Neuropathol 2010; 48: 75-80.
22. Spannuth WA, Sood AK, Coleman RL. Farletuzumab in epithelial ovarian carcinoma. Expert Opin Biol Ther 2010; 10: 431-437.
23. Suhardja A, Kovacs K, Rutka J. Genetic basis of pituitary adenoma invasiveness: A review. J Neurooncol 2001; 52: 195-204. (Pubitemid 33638518)
24. Townsend PA, Dublin E, Hart IR, Kao RH, Hanby AM, Cutress RI, Poulsom R, Ryder, K, Barnes DM, PackhamG. BAG-1 expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and vZhao X, Li H, Lee RJ. Targeted drug delivery via folate receptors. Expert Opin Drug Deliv 2008; 5: 309-319.